JP2001503447A - 老化皮膚の処置用組成物および方法 - Google Patents

老化皮膚の処置用組成物および方法

Info

Publication number: JP2001503447A
Authority: JP; Japan
Prior art keywords: skin; composition; cells; effective amount; adp
Prior art date: 1998-04-27
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP55424999A

Other languages

English (en)

Japanese (ja)

Inventor

マモーン，トーマス

エフ．コリンズ，ドナルド

Original Assignee

カラーアクセス，インコーポレイティド

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-04-27

Filing date

1999-04-22

Publication date

2001-03-13

1999-04-22 Application filed by カラーアクセス，インコーポレイティド filed Critical カラーアクセス，インコーポレイティド

2001-03-13 Publication of JP2001503447A publication Critical patent/JP2001503447A/ja

Status Pending legal-status Critical Current

Links

239000000203 mixture Substances 0.000 title claims abstract description 37
230000032683 aging Effects 0.000 title claims abstract description 14
238000000034 method Methods 0.000 title claims description 11
210000004027 cell Anatomy 0.000 claims abstract description 31
KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 claims abstract description 29
210000003491 skin Anatomy 0.000 claims abstract description 24
210000004927 skin cell Anatomy 0.000 claims abstract description 14
239000003581 cosmetic carrier Substances 0.000 claims abstract description 6
239000003937 drug carrier Substances 0.000 claims abstract description 6
210000002950 fibroblast Anatomy 0.000 claims description 12
239000002537 cosmetic Substances 0.000 claims description 9
239000008194 pharmaceutical composition Substances 0.000 claims description 6
206010040799 Skin atrophy Diseases 0.000 claims description 3
230000037303 wrinkles Effects 0.000 claims description 2
208000024891 symptom Diseases 0.000 claims 1
230000000699 topical effect Effects 0.000 abstract description 7
239000013543 active substance Substances 0.000 description 10
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
230000001413 cellular effect Effects 0.000 description 6
239000003795 chemical substances by application Substances 0.000 description 6
230000001684 chronic effect Effects 0.000 description 5
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
206010051246 Photodermatosis Diseases 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000004480 active ingredient Substances 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000037319 collagen production Effects 0.000 description 3
230000007423 decrease Effects 0.000 description 3
238000009472 formulation Methods 0.000 description 3
230000008845 photoaging Effects 0.000 description 3
-1 retinyl butyrate Chemical compound 0.000 description 3
230000000475 sunscreen effect Effects 0.000 description 3
239000000516 sunscreening agent Substances 0.000 description 3
210000001519 tissue Anatomy 0.000 description 3
PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
GHPVDCPCKSNJDR-UHFFFAOYSA-N 2-hydroxydecanoic acid Chemical compound CCCCCCCCC(O)C(O)=O GHPVDCPCKSNJDR-UHFFFAOYSA-N 0.000 description 2
YDZIJQXINJLRLL-UHFFFAOYSA-N 2-hydroxydodecanoic acid Chemical compound CCCCCCCCCCC(O)C(O)=O YDZIJQXINJLRLL-UHFFFAOYSA-N 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 2
CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 2
BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
108060001084 Luciferase Proteins 0.000 description 2
239000005089 Luciferase Substances 0.000 description 2
DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 2
LCTONWCANYUPML-UHFFFAOYSA-N Pyruvic acid Chemical compound CC(=O)C(O)=O LCTONWCANYUPML-UHFFFAOYSA-N 0.000 description 2
VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
CVSVTCORWBXHQV-UHFFFAOYSA-N anhydrous creatine Natural products NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
230000003712 anti-aging effect Effects 0.000 description 2
230000032677 cell aging Effects 0.000 description 2
230000003915 cell function Effects 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
239000003086 colorant Substances 0.000 description 2
229960003624 creatine Drugs 0.000 description 2
239000006046 creatine Substances 0.000 description 2
230000006378 damage Effects 0.000 description 2
239000000839 emulsion Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
ROBFUDYVXSDBQM-UHFFFAOYSA-N hydroxymalonic acid Chemical compound OC(=O)C(O)C(O)=O ROBFUDYVXSDBQM-UHFFFAOYSA-N 0.000 description 2
238000000338 in vitro Methods 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
210000002510 keratinocyte Anatomy 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
230000002265 prevention Effects 0.000 description 2
238000011084 recovery Methods 0.000 description 2
230000010076 replication Effects 0.000 description 2
QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
102220240796 rs553605556 Human genes 0.000 description 2
YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
230000009758 senescence Effects 0.000 description 2
230000009759 skin aging Effects 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical class CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
AFENDNXGAFYKQO-UHFFFAOYSA-N 2-hydroxybutyric acid Chemical compound CCC(O)C(O)=O AFENDNXGAFYKQO-UHFFFAOYSA-N 0.000 description 1
BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
FIYQGZWUDCJKNO-UHFFFAOYSA-N 2-oxobutanedioic acid Chemical compound OC(=O)CC(=O)C(O)=O.OC(=O)CC(=O)C(O)=O FIYQGZWUDCJKNO-UHFFFAOYSA-N 0.000 description 1
HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
241000195940 Bryophyta Species 0.000 description 1
239000004358 Butane-1, 3-diol Substances 0.000 description 1
FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
102000016942 Elastin Human genes 0.000 description 1
108010014258 Elastin Proteins 0.000 description 1
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
241000282412 Homo Species 0.000 description 1
NGEWQZIDQIYUNV-UHFFFAOYSA-N L-valinic acid Natural products CC(C)C(O)C(O)=O NGEWQZIDQIYUNV-UHFFFAOYSA-N 0.000 description 1
YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
208000012641 Pigmentation disease Diseases 0.000 description 1
206010063493 Premature ageing Diseases 0.000 description 1
208000032038 Premature aging Diseases 0.000 description 1
IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
229920002125 Sokalan® Polymers 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
IAJILQKETJEXLJ-RSJOWCBRSA-N aldehydo-D-galacturonic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-RSJOWCBRSA-N 0.000 description 1
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
XJKITIOIYQCXQR-SCUNHAKFSA-N all-trans-retinyl linoleate Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C XJKITIOIYQCXQR-SCUNHAKFSA-N 0.000 description 1
FXKDHZXYYBPLHI-TUTABMRPSA-N all-trans-retinyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FXKDHZXYYBPLHI-TUTABMRPSA-N 0.000 description 1
150000001280 alpha hydroxy acids Chemical class 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
229920006318 anionic polymer Polymers 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
150000001277 beta hydroxy acids Chemical class 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
235000019437 butane-1,3-diol Nutrition 0.000 description 1
HEZMRBNCRSVIHU-UHFFFAOYSA-N calcium boric acid dihypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-].OB(O)O HEZMRBNCRSVIHU-UHFFFAOYSA-N 0.000 description 1
229960001631 carbomer Drugs 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229920006317 cationic polymer Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
238000001246 colloidal dispersion Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
239000006071 cream Substances 0.000 description 1
GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
230000007547 defect Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
FMGSKLZLMKYGDP-USOAJAOKSA-N dehydroepiandrosterone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC=C21 FMGSKLZLMKYGDP-USOAJAOKSA-N 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
231100000673 dose–response relationship Toxicity 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000002500 effect on skin Effects 0.000 description 1
230000000694 effects Effects 0.000 description 1
229920002549 elastin Polymers 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 1
235000019634 flavors Nutrition 0.000 description 1
239000006260 foam Substances 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
239000000499 gel Substances 0.000 description 1
235000011187 glycerol Nutrition 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
230000003779 hair growth Effects 0.000 description 1
239000003906 humectant Substances 0.000 description 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
239000006210 lotion Substances 0.000 description 1
239000001630 malic acid Substances 0.000 description 1
229940099690 malic acid Drugs 0.000 description 1
235000011090 malic acid Nutrition 0.000 description 1
229960002510 mandelic acid Drugs 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
229960002216 methylparaben Drugs 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
239000002480 mineral oil Substances 0.000 description 1
235000010446 mineral oil Nutrition 0.000 description 1
235000011929 mousse Nutrition 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
229960001679 octinoxate Drugs 0.000 description 1
239000003921 oil Substances 0.000 description 1
KHPXUQMNIQBQEV-UHFFFAOYSA-L oxaloacetate(2-) Chemical compound [O-]C(=O)CC(=O)C([O-])=O KHPXUQMNIQBQEV-UHFFFAOYSA-L 0.000 description 1
JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 1
FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
230000037361 pathway Effects 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
229940107700 pyruvic acid Drugs 0.000 description 1
TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 description 1
230000005855 radiation Effects 0.000 description 1
239000011347 resin Substances 0.000 description 1
229920005989 resin Polymers 0.000 description 1
230000004044 response Effects 0.000 description 1
229930002330 retinoic acid Natural products 0.000 description 1
229960003471 retinol Drugs 0.000 description 1
235000020944 retinol Nutrition 0.000 description 1
239000011607 retinol Substances 0.000 description 1
229960000342 retinol acetate Drugs 0.000 description 1
235000019173 retinyl acetate Nutrition 0.000 description 1
239000011770 retinyl acetate Substances 0.000 description 1
229940071220 retinyl linoleate Drugs 0.000 description 1
229940108325 retinyl palmitate Drugs 0.000 description 1
235000019172 retinyl palmitate Nutrition 0.000 description 1
239000011769 retinyl palmitate Substances 0.000 description 1
229960004889 salicylic acid Drugs 0.000 description 1
230000037380 skin damage Effects 0.000 description 1
210000001626 skin fibroblast Anatomy 0.000 description 1
235000019333 sodium laurylsulphate Nutrition 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
239000003381 stabilizer Substances 0.000 description 1
230000001629 suppression Effects 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
230000001225 therapeutic effect Effects 0.000 description 1
235000010384 tocopherol Nutrition 0.000 description 1
229960001295 tocopherol Drugs 0.000 description 1
229930003799 tocopherol Natural products 0.000 description 1
239000011732 tocopherol Substances 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000032258 transport Effects 0.000 description 1
229960001727 tretinoin Drugs 0.000 description 1
230000007306 turnover Effects 0.000 description 1
239000003981 vehicle Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
238000004078 waterproofing Methods 0.000 description 1
239000000230 xanthan gum Substances 0.000 description 1
229920001285 xanthan gum Polymers 0.000 description 1
229940082509 xanthan gum Drugs 0.000 description 1
235000010493 xanthan gum Nutrition 0.000 description 1
239000011787 zinc oxide Substances 0.000 description 1
GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Dermatology (AREA)
Birds (AREA)
Epidemiology (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Emergency Medicine (AREA)
Gerontology & Geriatric Medicine (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

JP55424999A 1998-04-27 1999-04-22 老化皮膚の処置用組成物および方法 Pending JP2001503447A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US6705998A	1998-04-27	1998-04-27
US09/067,059		1998-04-27
PCT/US1999/008497 WO1999055302A1 (fr)	1998-04-27	1999-04-22	Composition destinee au traitement du vieillissement de la peau

Publications (1)

Publication Number	Publication Date
JP2001503447A true JP2001503447A (ja)	2001-03-13

Family

ID=22073462

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP55424999A Pending JP2001503447A (ja)	1998-04-27	1999-04-22	老化皮膚の処置用組成物および方法

Country Status (6)

Country	Link
EP (1)	EP1003473A1 (fr)
JP (1)	JP2001503447A (fr)
KR (1)	KR100426753B1 (fr)
AU (1)	AU744295B2 (fr)
CA (1)	CA2294482C (fr)
WO (1)	WO1999055302A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008524256A (ja) *	2004-12-17	2008-07-10	アランビー．キャッシュ	寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
JP2009298752A (ja) *	2008-06-17	2009-12-24	Shiseido Co Ltd	皮膚外用剤組成物
JP2012530683A (ja) *	2009-06-19	2012-12-06	大塚製薬株式会社	皮膚水分透過機能異常の予防又は治療剤

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6242491B1 (en)	1999-06-25	2001-06-05	Rima Kaddurah-Daouk	Use of creatine or creatine compounds for skin preservation
US7994153B2 (en)	2002-05-20	2011-08-09	Otsuka Pharmaceutical Co., Ltd.	Chloasma amelioration composition and dullness amelioration composition
JP4129574B2 (ja)	2002-08-06	2008-08-06	大塚製薬株式会社	老化防止剤
JP5093998B2 (ja) *	2004-09-22	2012-12-12	大塚製薬株式会社	色素沈着予防又は改善剤
KR101283303B1 (ko) *	2007-01-31	2013-07-12	(주)아모레퍼시픽	조성물 내 ｐＨ 조절을 통해 안정화된 α케토 산(αｋｅｔｏａｃｉｄ)을 함유하는 피부 외용제 조성물 및 그 α케토 산 안정화 방법
ES2950096T3 (es)	2016-09-22	2023-10-05	Alan B Cash	Método para aliviar los síntomas del síndrome premenstrual

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2557452B1 (fr) *	1983-12-28	1986-08-14	Roussel Uclaf	Nouvelles compositions pour les soins de la peau renfermant de l'huile d'onagre et des traits tissulaires de rate
US5256649A (en) *	1989-05-23	1993-10-26	Elf Sanofi	Cosmetic composition against aging of the skin
JP2844103B2 (ja) *	1990-02-09	1999-01-06	株式会社コーセー	皮膚外用剤
JP3413220B2 (ja) *	1992-08-17	2003-06-03	株式会社コーセー	肌荒れ改善剤
JP3172599B2 (ja) *	1992-10-16	2001-06-04	株式会社コーセー	細胞賦活剤
JPH0899860A (ja) *	1994-09-30	1996-04-16	Kose Corp	皮膚外用剤
JP3578858B2 (ja) *	1995-12-11	2004-10-20	株式会社ノエビア	皮膚外用剤

1999
- 1999-04-22 KR KR10-1999-7012177A patent/KR100426753B1/ko not_active Expired - Lifetime
- 1999-04-22 CA CA002294482A patent/CA2294482C/fr not_active Expired - Lifetime
- 1999-04-22 JP JP55424999A patent/JP2001503447A/ja active Pending
- 1999-04-22 AU AU37504/99A patent/AU744295B2/en not_active Expired
- 1999-04-22 WO PCT/US1999/008497 patent/WO1999055302A1/fr not_active Ceased
- 1999-04-22 EP EP99919884A patent/EP1003473A1/fr not_active Ceased

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2008524256A (ja) *	2004-12-17	2008-07-10	アランビー．キャッシュ	寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
JP2013100323A (ja) *	2004-12-17	2013-05-23	Alan B Cash	寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
JP2015145417A (ja) *	2004-12-17	2015-08-13	アランビー．キャッシュ	寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
JP2017019864A (ja) *	2004-12-17	2017-01-26	アランビー．キャッシュ	寿命を拡大させ、かつ加齢関連疾患の発症を遅らせるための方法
JP2009298752A (ja) *	2008-06-17	2009-12-24	Shiseido Co Ltd	皮膚外用剤組成物
JP2012530683A (ja) *	2009-06-19	2012-12-06	大塚製薬株式会社	皮膚水分透過機能異常の予防又は治療剤

Also Published As

Publication number	Publication date
KR100426753B1 (ko)	2004-04-13
AU3750499A (en)	1999-11-16
CA2294482C (fr)	2007-01-16
EP1003473A1 (fr)	2000-05-31
CA2294482A1 (fr)	1999-11-04
AU744295B2 (en)	2002-02-21
WO1999055302A1 (fr)	1999-11-04
KR20010014120A (ko)	2001-02-26

Legal Events

Date	Code	Title	Description
2004-02-05	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040115
2004-03-30	A02	Decision of refusal	Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20040330
2004-07-29	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040728
2004-09-01	A911	Transfer to examiner for re-examination before appeal (zenchi)	Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20040902
2004-09-22	A912	Re-examination (zenchi) completed and case transferred to appeal board	Free format text: JAPANESE INTERMEDIATE CODE: A912 Effective date: 20040916
2006-11-17	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20061116
2006-11-22	A602	Written permission of extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20061121

Publication	Publication Date	Title
KR100544570B1 (ko)	2006-01-24	민감성 피부를 치료하는 조성물을 제조하기 위한 복합체의 사용방법, 제조 방법 및 저알레르기성 조성물
JP3112436B2 (ja)	2000-11-27	特に、皮膚の顔貌の明るさを改良し、皺を処置するための角質溶解剤としての蜂蜜の使用
CN101431997B (zh)	2013-01-09	基于褪黑素和免疫抑制物质的组合成分
US20030064049A1 (en)	2003-04-03	Topical anti-cancer compositions and methods of use thereof
WO2002015860A1 (fr)	2002-02-28	Antioxydant topique a base de vitamine c et procede de combinaison avec agent topique par l'utilisateur
WO2002049656A1 (fr)	2002-06-27	Preparations externes pour la peau et leur procede de production
JP2002528480A (ja)	2002-09-03	グルタチオン産生を向上させる局所組成物
JP2000191498A (ja)	2000-07-11	コラ―ゲン産生促進剤および皮膚外用剤
CN109846740B (zh)	2022-05-17	皮肤护理组合物及其制备方法和应用
CN111000748A (zh)	2020-04-14	一种多肽修护面霜及其制备方法
CN115721595A (zh)	2023-03-03	身体用乳液及其制备方法
JP3842558B2 (ja)	2006-11-08	角質層機能の増強のための硫酸コレステロール組成物
JP2001097888A (ja)	2001-04-10	外用組成物
CN115154360B (zh)	2023-10-24	一种具有美白祛斑及保湿功效的组合物及其应用
JP2000327550A (ja)	2000-11-28	皮膚外用剤
CN115025001B (zh)	2023-12-05	一种具有多重美白祛斑功效的胜肽组合物及其应用
KR100426753B1 (ko)	2004-04-13	피부 노화 치료 조성물 및 방법
WO1991001128A1 (fr)	1991-02-07	Composition pour la peau permettant de reparer les effets du photovieillissement
CA1095413A (fr)	1981-02-10	Traduction non-disponible
JP2000212026A (ja)	2000-08-02	皮膚外用剤
JPH10114670A (ja)	1998-05-06	外用に適する組成物
JPH0899860A (ja)	1996-04-16	皮膚外用剤
CN113693966A (zh)	2021-11-26	一种创新型美白亮采祛斑霜及其制备方法
JP3104938B2 (ja)	2000-10-30	化粧料
JP2002370962A (ja)	2002-12-24	美白用化粧料および皮膚老化防止・改善用化粧料